Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Romain Casey"'
Autor:
Audrey Gauthier, Sébastien Viel, Magali Perret, Guillaume Brocard, Romain Casey, Christine Lombard, Sabine Laurent‐Chabalier, Marc Debouverie, Gilles Edan, Sandra Vukusic, Christine Lebrun‐Frénay, Jérôme De Sèze, David Axel Laplaud, Giovanni Castelnovo, Olivier Gout, Aurélie Ruet, Thibault Moreau, Olivier Casez, Pierre Clavelou, Eric Berger, Hélène Zephir, Sophie Trouillet‐Assant, Eric Thouvenot, OFSEP Investigators
Publikováno v:
Annals of Clinical and Translational Neurology, Vol 8, Iss 5, Pp 1141-1150 (2021)
Abstract We compared SimoaTM and EllaTM immunoassays to assess serum neurofilament‐light chain levels in 203 multiple sclerosis patients from the OFSEP HD study. There was a strong correlation (ρ = 0.86, p
Externí odkaz:
https://doaj.org/article/065e81b4c5174e9fa867174580f930de
Autor:
Olivier Commowick, Michaël Kain, Romain Casey, Roxana Ameli, Jean-Christophe Ferré, Anne Kerbrat, Thomas Tourdias, Frédéric Cervenansky, Sorina Camarasu-Pop, Tristan Glatard, Sandra Vukusic, Gilles Edan, Christian Barillot, Michel Dojat, Francois Cotton
Publikováno v:
NeuroImage, Vol 244, Iss , Pp 118589- (2021)
MRI plays a crucial role in multiple sclerosis diagnostic and patient follow-up. In particular, the delineation of T2-FLAIR hyperintense lesions is crucial although mostly performed manually - a tedious task. Many methods have thus been proposed to a
Externí odkaz:
https://doaj.org/article/b1a128cbc9dd4283a9f90ceb94aa775c
Autor:
Clarisse Carra-Dallière, Fabien Rollot, Romain Deschamps, Jonathan Ciron, Sandra Vukusic, Bertrand Audoin, Aurélie Ruet, Elisabeth Maillart, Caroline Papeix, Hélène Zephir, David Laplaud, Mikael Cohen, Bertrand Bourre, Illiasse El-Bahi, Pierre Labauge, Romain Casey, Xavier Ayrignac, Romain Marignier
Publikováno v:
Multiple Sclerosis Journal. 29:270-276
Background and objective: Myelin-oligodendrocyte glycoprotein (MOG) antibody-associated disease (MOGAD) frequently initiates during childbearing years. This study investigated the impact of pregnancy and post-partum on MOGAD activity. Methods: Retros
Autor:
Mathilde, Lefort, Sandra, Vukusic, Romain, Casey, Gilles, Edan, Emmanuelle, Leray, Chantal, Nifle
Publikováno v:
European Journal of Neurology
European Journal of Neurology, 2022, 29 (9), pp.2761-2771. ⟨10.1111/ene.15422⟩
European Journal of Neurology, Wiley, 2022, ⟨10.1111/ene.15422⟩
European Journal of Neurology, 2022, 29 (9), pp.2761-2771. ⟨10.1111/ene.15422⟩
European Journal of Neurology, Wiley, 2022, ⟨10.1111/ene.15422⟩
International audience; BACKGROUND: Therapeutic management of relapsing-remitting multiple sclerosis (RRMS) has evolved towards early treatment. The objective was to assess the impact of early treatment initiation on disability progression among RRMS
Autor:
Camille Sabathé, Romain Casey, Sandra Vukusic, Emmanuelle Leray, Guillaume Mathey, Jérôme De Sèze, Jonathan Ciron, Sandrine Wiertlewski, Aurélie Ruet, Jean Pelletier, Hélène Zéphir, Laure Michel, Christine Lebrun-Frenay, Xavier Moisset, Eric Thouvenot, Jean-Philippe Camdessanché, Serge Bakchine, Bruno Stankoff, Abdullatif Al Khedr, Philippe Cabre, Elisabeth Maillart, Eric Berger, Olivier Heinzlef, Karolina Hankiewicz, Thibault Moreau, Olivier Gout, Bertrand Bourre, Abir Wahab, Pierre Labauge, Alexis Montcuquet, Gilles Defer, Aude Maurousset, Nicolas Maubeuge, Dalia Dimitri Boulos, Haïfa Ben Nasr, Chantal Nifle, Olivier Casez, David-Axel Laplaud, Yohann Foucher
Publikováno v:
Multiple Sclerosis Journal
Multiple Sclerosis Journal, 2023, 29 (2), pp.236-247. ⟨10.1177/13524585221139156⟩
Multiple Sclerosis Journal, 2023, 29 (2), pp.236-247. ⟨10.1177/13524585221139156⟩
Background: In relapsing-remitting multiple sclerosis (RRMS), early identification of suboptimal responders can prevent disability progression. Objective: We aimed to develop and validate a dynamic score to guide the early decision to switch from fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb0d295f009630c7a4453984a4cacd15
https://amu.hal.science/hal-04086418
https://amu.hal.science/hal-04086418
Autor:
Clarisse Carra-Dallière, Fabien Rollot, Romain Deschamps, Jonathan Ciron, Sandra Vukusic, Bertrand Audoin, Bertrand Bourre, Illiasse El-Bahi, Pierre Labauge, Aurélie Ruet, Elisabeth Maillart, Caroline Papeix, Hélène Zéphir, David Laplaud, Mikael Cohen, Romain Casey, Xavier Ayrignac, Romain Marignier
Publikováno v:
Revue Neurologique. 179:S162
Autor:
Fabien Rollot, Couturier Justine, Romain Casey, Emmanuelle Leray, Sandra Vukusic, David Laplaud
Publikováno v:
Revue Neurologique
Revue Neurologique, 2022, 178 (Suppl.), pp.S111. ⟨10.1016/j.neurol.2022.02.381⟩
Revue Neurologique, 2022, 178 (Suppl.), pp.S111. ⟨10.1016/j.neurol.2022.02.381⟩
International audience; IntroductionLors d’une persistance d’activité résiduelle sous fingolimod (FNG) chez des patients SEP récurrent rémittent (RR), la stratégie thérapeutique actuelle est basée sur un switch vers le natalizumab (NTZ) ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a1ee131cf49c77978551898c9d757cc
https://hal.ehesp.fr/hal-03820845
https://hal.ehesp.fr/hal-03820845
Autor:
Fabien Rollot, Justine Couturier, Romain Casey, Sandrine Wiertlewski, Marc Debouverie, Jean Pelletier, Jérôme De Sèze, Pierre Labauge, Aurélie Ruet, Eric Thouvenot, Jonathan Ciron, Eric Berger, Olivier Gout, Pierre Clavelou, Bruno Stankoff, Olivier Casez, Bertrand Bourre, Hélène Zephir, Thibault Moreau, Christine Lebrun-Frenay, Elisabeth Maillart, Gilles Edan, Jean-Philippe Neau, Alexis Montcuquet, Philippe Cabre, Jean-Philippe Camdessanché, Gilles Defer, Haifa Ben Nasr, Aude Maurousset, Karolina Hankiewicz, Corinne Pottier, Emmanuelle Leray, Sandra Vukusic, David-Axel Laplaud
Publikováno v:
Neurotherapeutics
Neurotherapeutics, 2022, 19 (2), pp.476-490. ⟨10.1007/s13311-022-01202-1⟩
Neurotherapeutics : the Journal of the American Society For Experimental
Neurotherapeutics : the Journal of the American Society For Experimental, 2022, ⟨10.1007/s13311-022-01202-1⟩
Neurotherapeutics, 2022, 19 (2), pp.476-490. ⟨10.1007/s13311-022-01202-1⟩
Neurotherapeutics : the Journal of the American Society For Experimental
Neurotherapeutics : the Journal of the American Society For Experimental, 2022, ⟨10.1007/s13311-022-01202-1⟩
In France, two therapeutic strategies can be offered after fingolimod (FNG) withdrawal to highly active relapsing–remitting multiple sclerosis (RRMS) patients: natalizumab (NTZ) or anti-CD20. We compared the effectiveness of these two strategies as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f52d6c446c6fcb69dd04da9f2f5743e3
https://hal.science/hal-03594074
https://hal.science/hal-03594074
Publikováno v:
Revue Neurologique. 178:S107-S108
Autor:
Katherine Buzzard, Dana Horáková, Guillermo Izquierdo, P. Grammond, S. Ozakbas, Francesco Patti, C. Boz, Tomas Kalincik, Francois Grand'Maison, Gilles Edan, E. K. Havrdova, Izanne Roos, Charles B Malpas, Ofsep Study Groups, Helmut Butzkueven, Jeannette Lechner-Scott, Jonathan Ciron, Sandra Vukusic, Emmanuelle Leray, Jean Pelletier, Sara Eichau Madueno, Oliver Gerlach, Pierre Clavelou, Olga Skibina, Marc Debouverie, Romain Casey, Maria Pia Amato
Publikováno v:
Neurology
Neurology, American Academy of Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
Neurology, American Academy of Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
Neurology, 2021, 97 (9), pp.e869-e880. ⟨10.1212/WNL.0000000000012354⟩
ObjectiveTo compare the clinical effectiveness of high- and low-efficacy treatments in patients with recently active and inactive secondary progressive multiple sclerosis (SPMS) after accounting for therapeutic lag.MethodsPatients treated with high-e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e92a18c1b372a4f4f2026f28b50f47d
https://hal.archives-ouvertes.fr/hal-03282036
https://hal.archives-ouvertes.fr/hal-03282036